Alexander Mark Schobel - Jun 8, 2022 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Chief Innovation/Tech Officer
Signature
/s/ Lori J. Braender, as Attorney-in-Fact
Stock symbol
AQST
Transactions as of
Jun 8, 2022
Transactions value $
$49,999
Form type
4
Date filed
6/10/2022, 05:26 PM
Previous filing
Mar 14, 2022
Next filing
Nov 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Purchase $44K +45.9K +5.48% $0.96 883K Jun 8, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Warrant (Right to Buy) Purchase $5.96K +45.9K $0.13* 45.9K Jun 8, 2022 Common Stock 45.9K $0.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13.